Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
Roivant Sciences Ltd. - 21 Feb 2025 SCHEDULE 13D/A Report for Arbutus Biopharma Corp Common Shares, without par value (ABUS)
- Filing manager
- Roivant Sciences Ltd.
- Reporting owner
- Roivant Sciences Ltd.
- Beneficially owned shares
- 38,847,462 shares
- Large-stake signal
-
Ownership
20%Beneficial ownership of this reported class.
Shares
38,847,462 sharesShares beneficially owned as disclosed.
Event date
21 Feb 2025Date tied to the ownership event or amendment.
Accepted by SEC
25 Feb 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 20%
- Symbol
- ABUS
- Shares outstanding
- 189,499,815 shares
- SEC form
- SCHEDULE 13D/A
- Accepted by SEC
- 25 Feb 2025, 07:19:33 UTC
- Event date
- 21 Feb 2025
- Prior SEC filing
- 18 Feb 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
5 source fields
Key filing fact
Roivant Sciences Ltd. disclosed 20% ownership in Arbutus Biopharma Corp Common Shares, without par value (ABUS) on 21 Feb 2025.
Key facts
- Roivant Sciences Ltd. filed SCHEDULE 13D/A for Arbutus Biopharma Corp Common Shares, without par value (ABUS).
- Disclosed ownership: 20%.
- Date of event: 21 Feb 2025.
Change
- Previous schedule filing date: 18 Feb 2025.
- Current filing was accepted on 25 Feb 2025, 07:19.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (1)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd. | 20% | 38,847,462 | 38,847,462 | 0 | /s/ Keyur Parekh | Keyur Parekh, Authorized Signatory | 0001635088 |
CIK / CUSIP context first